{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Unclear efficacy of protection against re-infections in people with and without symptoms at their initial SARS-CoV-2 infection\",\"Impact\":\"Uncertainty in determining the level of protection provided by natural immunity\",\"Mitigation\":\"Further evaluation of the efficacy of protection against re-infections in symptomatic and asymptomatic individuals\",\"Technologies\":\"Data analysis tools, research studies\",\"People\":\"Individuals with a history of SARS-CoV-2 infection\",\"Owner\":\"Health organizations, researchers\"},{\"Description\":\"Accumulating evidence on the efficacy and duration of natural immunity contributing to the mitigation of the COVID-19 pandemic\",\"Impact\":\"Increased reliance on natural immunity as a mitigation strategy without considering potential drawbacks\",\"Mitigation\":\"Balancing the reliance on natural immunity with other preventive and therapeutic measures such as vaccines\",\"Technologies\":\"Vaccines, preventive and therapeutic measures\",\"People\":\"Public health authorities, policymakers\",\"Owner\":\"Health organizations, government agencies\"}]}"}}